Table 2. Doses for target and organs at risk.
| Mean value (range) | ||
|---|---|---|
| PTV | Dmax (Gy) | 35.3±3.07 (32.1-43.0) |
| Dmean (Gy) | 32.4±2.13 (30.7-38.0) | |
| V96% (%) | 99.5±0.7 (98.0-100) | |
| V110% (%) | 0.7±1.2 (0-3.0) | |
| Left len | Dmax (Gy) | 4.8±1.6 (2.3-6.1) |
| Right len | Dmax (Gy) | 4.0±0.9 (1.4-5.0) |
| Left lung | V20 (%) | 0.3±0.3 (0-1.0) |
| V10 (%) | 6.2±3.2 (1.0-12.0) | |
| V5 (%) | 34.3±10.9 (12.0-47.0) | |
| Right lung | V20 (%) | 0.6±0.8 (0-2.0) |
| V10 (%) | 7.6±4.0 (1.0-15.0) | |
| V5 (%) | 37.4±12.9(11.0-61.0) | |
| Liver | V20 (%) | 0±0.1 (0-0.4) |
| V10 (%) | 4.7±5.4 (0-17.1) | |
| V5 (%) | 40.9±13.7 (12.0-56.6) | |
| Left kidney | V20 (%) | 0 (0) |
| V10 (%) | 5.2±3.9 (0-12.0) | |
| V5 (%) | 35.5±16.2 (13-69.5) | |
| Right kidney | V20 (%) | 0 (0) |
| V10 (%) | 3.0±2.8 (0.2-8.6) | |
| V5 (%) | 34.9±17.2 (7.5-63.3) |
PTV, planning target volume.